(Q37737556)

22 August 2017

1 reference

title

Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms (English)

1 reference

22 August 2017

1 reference

Assam El-Osta

2

0 references

author name string

Stephen Tonna

series ordinal

1

1 reference

22 August 2017

Mark E Cooper

series ordinal

3

1 reference

22 August 2017

Chris Tikellis

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

27 April 2010

1 reference

Nature Reviews Nephrology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

332-341

1 reference

The sorbitol pathway and the complications of diabetes

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Factors favoring successful transmetatarsal amputation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Nonenzymatic glycosylation, the Maillard reaction and the aging process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Update: standards of medical care in diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Diabetes and decline in heart disease mortality in US adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Unsuspected diabetes mellitus in peripheral vascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Diabetes Mellitus and Atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Evaluation of below-the-knee amputation in the treatment of diabetic gangrene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Transmetatarsal amputations and arterial surgery in diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Diabetic management in patients with renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Pathogenesis, prevention, and treatment of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Peripheral neuropathy as a sign of systemic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Focal neurological symptoms associated with uncontrolled diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The prevalence of diabetic retinopathy among adults in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Projecting the number of patients with end-stage renal disease in the United States to the year 2015

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Effect of a multifactorial intervention on mortality in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

10-year follow-up of intensive glucose control in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Images in clinical medicine. Paget's disease of the mandible

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Lowering blood pressure reduces renal events in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Glucose control and vascular complications in veterans with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Effects of intensive glucose lowering in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Accelerated age-related browning of human collagen in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Progression of incipient diabetic retinopathy during good glycemic control.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

DNA methylation landscapes: provocative insights from epigenomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Immunopathology of renal extracellular membranes in kidneys transplanted into patients with diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Podocyte loss and progressive glomerular injury in type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Is diabetic nephropathy an inherited complication?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23–q24 by association study in Russian type 1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genetics of diabetic nephropathy in the Pima Indians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Genetic aspects of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.55

31 March 2020

1 reference

12 December 2020

Renal biopsies performed on diabetics

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (2nd part) (author's transl)

1 reference

12 December 2020

Studies of diabetic nephropathy in animals and man

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

12 December 2020

Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group

1 reference

12 December 2020

COMMON ENZYME DEFICIENCIES MAY CAUSE ATHEROSCLEROSIS AND DIABETES MELLITUS.

1 reference

12 December 2020

Glucose control and the renal and retinal complications of insulin-dependent diabetes

1 reference

12 December 2020

Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy

1 reference

12 December 2020

Patterns of ischemia in diabetic retinopathy

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2010.55

1 reference

22 August 2017

1 reference